DEL LABORATORIES U.K. LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023
Del Laboratories U.K. Limited is a private company limited by shares incorporated in England and Wales, United Kingdom.
The address of the registered office is given in the Company Information page of these financial statements.
The Company did not trade during the year.
2.Accounting policies
|
|
Basis of preparation of financial statements
|
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The parent company, Coty Inc, has indicated its willingness and intention to provide ongoing support to the Company. Having considered this, the directors are confident that the Company will continue to receive support from its parent for a period of at least twelve months from the signing of the financial statements.
On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
|
The Company has no employees other than the directors, who did not receive any remuneration (2022 - £NIL).
|
|
Creditors: Amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts owed to group undertakings
|
|
|
|
|
|
|
|